Patents by Inventor Sam-Sik Kang

Sam-Sik Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for prevention or treatment of cognitive function disorders comprising spinosin
    Patent number: 9956242
    Abstract: The pharmaceutical composition of the present invention, which comprises spinosin or a spinosin-containing herbal extract, is a composition for preventing and treating cognitive function disorders, and can effectively improve memory and learning ability, and effectively treat and prevent cognitive function disorders such as dementia and amnesia.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: May 1, 2018
    Assignees: MINISTRY OF FOOD AND DRUG SAFETY, DAE HWA PHARMA, CO., LTD.
    Inventors: Jong Hoon Ryu, Hyung Eun Lee, Sam Sik Kang, Ju Sun Kim, So Young Lee, Do Hoon Kim, Dong Sup Kim, Seung Hee Kim
  • PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF COGNITIVE FUNCTION DISORDERS COMPRISING SPINOSIN
    Publication number: 20170065627
    Abstract: The pharmaceutical composition of the present invention, which comprises spinosin or a spinosin-containing herbal extract, is a composition for preventing and treating cognitive function disorders, and can effectively improve memory and learning ability, and effectively treat and prevent cognitive function disorders such as dementia and amnesia.
    Type: Application
    Filed: November 3, 2016
    Publication date: March 9, 2017
    Inventors: Jong Hoon RYU, Hyung Eun LEE, Sam Sik KANG, Ju Sun KIM, So Young LEE, Do Hoon KIM, Dong Sup KIM, Seung Hee KIM
  • PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF COGNITIVE FUNCTION DISORDERS COMPRISING SPINOSYN
    Publication number: 20150065441
    Abstract: The pharmaceutical composition of the present invention, which comprises spinosin or a spinosin-containing herbal extract, is a composition for preventing and treating cognitive function disorders, and can effectively improve memory and learning ability, and effectively treat and prevent cognitive function disorders such as dementia and amnesia.
    Type: Application
    Filed: November 30, 2012
    Publication date: March 5, 2015
    Inventors: Jong Hoon Ryu, Hyung Eun Lee, Sam Sik Kang, Ju Sun Kim, So Young Lee, Do Hoon Kim, Dong Sup Kim, Seung Hee Kim
  • Pharmaceutical composition comprising an extract of for the prevention and the treatment of diabetes and diabetic complications
    Patent number: 7192591
    Abstract: The present invention relates to an extract of Elfvingia applanata, which shows a therapeutic activity for diabetes and diabetic complications and a pharmaceutical composition for the treatment of diabetes and diabetic complications comprising the extract.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: March 20, 2007
    Inventors: Dal-Hoon Son, Sung-Soon Son, Kuk-Hyun Shin, Sam-Sik Kang
  • Pharmaceutical composition comprising an extract of Elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications
    Publication number: 20050142147
    Abstract: The present invention relates to an extract of Elfvingia applanata, which shows a therapeutic activity for diabetes and diabetic complications and a pharmaceutical composition for the treatment of diabetes and diabetic complications comprising the extract.
    Type: Application
    Filed: February 25, 2005
    Publication date: June 30, 2005
    Inventors: Dal-Hoon Son, Sung-Soon Son, Kuk-Hyun Shin, Sam-Sik Kang
  • Memory enhancing and anti-dementia agent containing dehydroevodiamine HC1 as active ingredient
    Patent number: 5859016
    Abstract: Dehydroevodiamine-HCl, a constituent of Evodia rutaecarpa Benth. (DHED) exhibits anti-AChE activity and improves the memory impairment of animals produced by scopolamine in the passive avoidance test. Thus, DHED can be a potent, long term memory enhancing and anti-dementia agent if it is used together with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: January 12, 1999
    Assignees: JE IL Pharmaceutical Co., Ltd., Yoo-Hun Suh
    Inventors: Yoo-Hun Suh, Sam-Sik Kang, Seong-Hun Kim, Cheol-Hyoung Park, Woong Choi